title: Subtotal excision with adjunctive sclerosing therapy for the treatment of severe symptomatic orbital lymphangiomas.
abstract: Orbital lymphangiomas are congenital malformations with abnormal and dead-end lymphatic channels and present management challenges to ophthalmologists and orbital surgeons. Recurrent hemorrhage and expansion can lead to vision loss and disfigurement. We report our technique that uses adjunctive intraoperative injection of sodium morrhuate, 5%, under direct visualization into lymphangioma channels prior to excision. We believe that in the hands of experienced orbital surgeons, and with appropriate preoperative evaluation and careful surgical technique, this procedure is useful in saving vision and avoiding complications from orbital lymphangiomas.
authors.affiliation: Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, 48105, USA. akahana@med.umich.edu
authors.forename: Alon
authors.initials: A
authors.lastname: Kahana
authors.forename: Brenda L
authors.initials: BL
authors.lastname: Bohnsack
authors.forename: Raymond I
authors.initials: RI
authors.lastname: Cho
authors.forename: Cormac O
authors.initials: CO
authors.lastname: Maher
mesh_terms: D000328:Adult; D017024:Chemotherapy, Adjuvant; D002648:Child; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D007430:Intraoperative Care; D008202:Lymphangioma / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D018810:Magnetic Resonance Angiography; D013508:Ophthalmologic Surgical Procedures; D009918:Orbital Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D012189:Retrospective Studies; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D012976:Sodium Morrhuate / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed
chemical_list: D012597:Sclerosing Solutions; D012976:Sodium Morrhuate